Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
 
  Phillip Investor Notes

26-09-2017(Tue) 25-09-2017(Mon) 22-09-2017(Fri) 21-09-2017(Thu) 20-09-2017(Wed)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes *Advertisement*
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
26 Sep, 2017 (Tuesday)

            
CHINA XLX FERT(1866)
Analysis¡G
China XLX Fertiliser (1866) is principally engaged in the manufacturing and trading of urea, compound fertiliser, methanol, melamine, furfuryl alcohol, liquid ammonia and ammonia solution. In the first half of 2017, although the urea market remained sluggish, demand for compound fertiliser, melamine, methanol and liquid ammonia recovered substantially and helped increase the Group`s revenue by 24% to RMB3.574 billion and Group`s net profit increased 1.1 times to RMB173 million. Overall gross profit margin remained at 19% in 1H2017 which is the same as that of 1H2016. (I do not hold the above stock)
Strategy¡G
Buy-in Price: $2.35, Target Price: $2.60, Cut Loss Price: $2.20

NT PHARMA(1011)
Analysis¡G
China NT Pharma Group (1011) is engaged in providing integrated vaccines supply chain, and providing promotionand sales services for vaccines and pharmaceutical products in China, with its products covering therapeutic areas such as oncology, orthopedics, CNS, hepatopathy and respiratory system. The Group recently announced that the project on the new indication "myelodysplastic syndrome (MDS)" of "Xi Di Ke" (uroacitides injection) had been admitted into the "Major New Drugs Innovation" projects of the Ministry of Science and Technology and the National Health and Family Planning Commission, and received central subsidy funding from the Ministry of Finance.
Strategy¡G
Buy-in Price: $1.96, Target Price: $2.28, Cut Loss Price: $1.80


Dynagreen (1330. HK) - Keeps Increasing on Its Operational Level and Its Valuation May Possibly Recover

Summary of Investment

There is a great increase in its operational business and a slight growth in its profit quality;

It will enter construction period in H2 and its construction businesses is expected to go back to rapid growth;

Its IPO in A-share market is carrying forward steadily.

Investment Advice

The company is gaining in its operational level, has rich project reserves at hand and has strong certainty about its performance growth in the following years. It is launching its IPO in A-share market, which is expected to be completed at the end of the year, and the low valuation of its H-share may be improved at that time. We estimate, from 2017 to 2018, the net profit of the company will reach 465/580mn, and respectively, EPS of 0.45/0.56, equivalent to an PE of 8.1/6.5. We give a target price of HKD 6.40 and the Buy rating. (Closing price as at 22 Sep 2017)

Environmental energy business contributed to main revenue increments

In H1 of 2017, Dynagreen reported, respectively, an operating revenue and a profit of, respectively, RMB985 million and RMB193 million, increasing by, respectively, 18.4% and 16.45%, equivalent to an EPS of RMB0.18 compared to an EPS of RMB0.16 in the previous year. The major increment contributed to operational business went up significantly by 57% to RMB331 million and the income from construction revenue grew slightly by 2.94% yoy to RMB567 million.

In terms of profitability, the overall gross margin increased by 0.79 ppts yoy to 32.35% thanks to the increase in proportion of high gross profit operational business, but the net profit margin went down by 0.33 ppts yoy to 19.57% because the period cost rate went up by 1 ppts yoy to 12.65% due to the rapid growth in administration and finance expenses.

The operation index hits a new high

The operation quality of projects put into operation improves significantly and the garbage treatment volume and on-grid energy hit a new high. The company has put into operation 11 projects, mainly located in economically developed areas like Beijing-Tianjin-Hebei region, Yangtze River Delta and Pearl River Delta. The garbage treatment volume and on-grid energy increased by 15% and 36% respectively, to 1.75 million tons and 470 million kWh. The waste incineration plants in operation is able to dispose of garbage of 8550 tons. The operation and management capacity of the company can be seen by the fact that it owns 3 out of 11 3A-level (the highest) household garbage incineration plants domestically, respectively in Huizhou, Wuhan and Taizhou, chosen by Central Environmental Protection Association With the continuous increases in the demand of local household garbage disposal and the proportion of the household garbage disposal capacity, the operational business is anticipated to grow rapidly.

The project construction and expansion progress well

Among the projects under construction, Jurong Project(700t/d) was put into trial operation in April and Ninghe Straw Project(700t/d) has finished construction by more than 90%, Bangbu Project(1210t/d) more than70%, Tongzhou Project more than 45% and they are expected to be put into trial operation in H2 this year and H1 next year. Besides, Miyun PPP Project(1530t/d) and Shantou Project(1500t/d) is under full construction and Bobai, Zhangqiu, Hongan and Longhui Projects are under preparation. H2 this year and next year will be an intensive construction period and the construction businesses are expected to see a huge rise.

In terms of project expansion, the company is both actively developing new projects and rebuilding or expanding existing projects. Up to now, the company has signed a new contract of Tongzhou Second-phase Project and Yongjia Reconstruction-Promotion PPP Project(including a second-phase project), respectively increase disposal capacity by 1700t/d and 750t/d. The scale of projects under construction or preparation reaches 18390t/d, equivalent to 2 times of the scale of existing operational projects. Benefiting from abundant projects reserve, there is absolutely adequate incentive for result growth in the following years.

Investment Advice

The company is gaining in its operational level, has rich project reserves at hand and has strong certainty about its performance growth in the following years. It is launching its IPO in A-share market, which is expected to be completed at the end of the year, and the low valuation of its H-share may be improved at that time. We estimate, from 2017 to 2018, the net profit of the company will reach 465/580mn, and respectively, EPS of 0.45/0.56, equivalent to an PE of 8.1/6.5. We give a target price of HKD 6.40 and the Buy rating.

Risk Warnings

The existing projects development falls short of expectation;

The acquisition of new projects falls short of expectation;

The progress of IPO falls short of expectation;

Capital and policy risks occur.

Financials

Click Here for PDF format...




Recommendation on 26-9-2017
RecommendationBuy
Price on Recommendation Date$ 4.320
Suggested purchase priceN/A
Target Price$ 6.400
Writer Info
Wang Yannan
(Research Analyst)
Tel: 86 21 51699400-107
Email:
wangyannan@phillip.com.cn

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Phillip Research - Hong Kong ½÷¥ß¬ã¨s³¡ ¡V ­»´ä¤Î¤¤°ê
Company Stock Code Last Update Suggestion Target Price Price on Recom
Information Techology Research Department N/A+852 2277 6527research@phillip.com.hk
Karrie International105015/09/2017No Rating1.24
Goldpac Group331527/03/2017Buy32.4
Transportation and Automobiles Zhang Jing (86) 2151699200-103zhangjing@phillip.com.cn
GAC223825/09/2017BUY24.6519.06
BAIC195818/09/2017Accumulate7.626.95
Insurance Research Department (86) 21 51699400-110research@phillip.com.cn
Media & Publishing Research Department (+ 86 21 51699400-107)research@phillip.com.cn
Wisdom Sports Group166111/07/2016Buy3.32.18
NetDragon77716/06/2016Buy28.422.9
Pharmaceutical Fan Guohe  (+ 86 21 51699400-110)fanguohe@phillip.com.cn
Tasly Pharmaceutical Group600535.CH24/08/2017Accumulate43.838.52
Hengrui Medicine60027602/08/2017Accumulate 56.551.2
Industrial Goods Ocean Pan +852 2277 6515oceanpan@phillip.com.hk
DONGJIANG ENV89511/08/2017Buy13.810.64
DONGJIANG ENV89515/05/2017Buy14.812.16
Health & Personal Care Fan Guohe  (+ 86 21 51699400-110)fanguohe@phillip.com.cn
HEC Pharm155802/06/2017Buy22.2417.08
Luye Pharma218622/03/2017Buy6.34.95
New Energy Wang Yannan 86 21 51699400-107wangyannan@phillip.com.cn
HN RENEWABLES95827/02/2017Buy3.52.72
CONCORD NE18224/10/2016Buy0.60.39
Food, Beverage and Retail Research Department (86) 21 51699400-110research@phillip.com.cn
L`OCCITANE97322/05/2017Accumulate1715.3
L`OCCITANE97319/05/2017Accumulate1715.3
Textiles & Clothing Ocean Pan +852 2277 6515oceanpan@phillip.com.hk
JNBY330613/04/2017Accumulate6.65.95
CECEP COSTIN New Materials Group222818/10/2013Buy5.64.23
Telecommunications Fan Guohe + (86) 21 51699400-110fanguohe@phillip.com.cn
Chinasoft International35409/08/2017Buy5.884.39
Chinasoft International Ltd35410/04/2017Buy5.84.61
Mainland Property John Wong +852 2277 6527johnycwong@phillip.com.hk
KWG Property181314/09/2017Neutral8.48.47
Logan Property338021/08/2017Buy8.87.28
Basic Materials Ocean Pan +852 2277 6515oceanpan@phillip.com.hk
Yip's Chemical40815/06/2017No Rating3.29
ND Paper268905/04/2017Accumulate9.58.35
Utilities Research Department +852 2277 6527research@phillip.com.hk
Dynagreen133026/09/2017Buy6.400.000
Grandblue ENV60032319/09/2017Accumulate17.414.83
Properties John Wong +852 2277 6527johnycwong@phillip.com.hk
K. Wah International17322/09/2017Buy5.94.85
K. Wah International17321/09/2017Buy5.94.85
Software & Service Research Department (86) 21 51699400-110research@phillip.com.cn
IGG800221/11/2014Accumulate3.953.44
HC INTERNATIONAL228006/11/2014Buy14.928.8
Hotels and Entertainment John Wong (+ 852 2277 6527)johnycwong@phillip.com.hk
Hongkong & Shanghai Hotels4516/08/2017Neutral12.513.18
Hongkong & Shanghai Hotels4515/08/2017Neutral12.513.18

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2017 Phillip Securities (HK) Ltd. All Rights Reserved.


Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]